DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
« Back to Dashboard
Avibactam sodium; ceftazidimeis the generic ingredient in one branded drug marketed by Allergan and is included in one NDA. There are eight patents protecting this compound. Additional information is available in the individual branded drug profile pages.
Avibactam sodium; ceftazidime has one hundred and ninety-three patent family members in fifty-four countries.
One supplier is listed for this compound.
Pharmacology for avibactam sodium; ceftazidime
|Drug Class||Cephalosporin Antibacterial |
beta Lactamase Inhibitor
|Mechanism of Action||beta Lactamase Inhibitors |
Anatomical Therapeutic Chemical (ATC) Classes for avibactam sodium; ceftazidime
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||Patent No.||Patent Expiration|
|Allergan||AVYCAZ||avibactam sodium; ceftazidime||POWDER;INTRAVENOUS||206494-001||Feb 25, 2015||⤷ Free Forever Trial||⤷ Free Forever Trial|
|>Applicant||>Tradename||>Generic Name||>Dosage||>NDA||>Approval Date||>Patent No.||>Patent Expiration|
|Country||Patent Number||Estimated Expiration|
|Taiwan||I565706||⤷ Free Forever Trial|
|China||102834395||⤷ Free Forever Trial|
|Russian Federation||2017102358||⤷ Free Forever Trial|
|Slovenia||1307457||⤷ Free Forever Trial|
|Poland||234468||⤷ Free Forever Trial|
|South Korea||102143660||⤷ Free Forever Trial|
|>Country||>Patent Number||>Estimated Expiration|
|Patent Number||Supplementary Protection Certificate||SPC Country||SPC Expiration||SPC Description|
|1480644||2016C/069||Belgium||⤷ Free Forever Trial||PRODUCT NAME: ZAVICEFTA (COMBINAISON DE CEFTAZIDIME ET AVIBACTAM); AUTHORISATION NUMBER AND DATE: EU/1/16/1109/001 20160628|
|1480644||1690059-9||Sweden||⤷ Free Forever Trial||PRODUCT NAME: PHARMACEUTICAL MIXTURE OR ASSOCIATION THAT INCLUDES AS ACTIVE INGREDIENTS: (1) CEFTAZIDIME OR A SALT THEREOF, AND (2) AVIBACTAM OR A SALT THEREOF; REG. NO/DATE: EU/1/16/1109 20160628|
|1480644||SPC/GB17/004||United Kingdom||⤷ Free Forever Trial||PRODUCT NAME: COMBINATION OF CEFTAZIDIME, OR A SALT THEREOF, AND AVIBACTAM, OR A SALT THEREOF; REGISTERED: UK EU/1/16/1109/001 20160628|
|1480644||300847||Netherlands||⤷ Free Forever Trial||DETAILS ASSIGNMENT: CHANGE OF OWNER(S), ASSIGNMENT|
|1480644||2016/056||Ireland||⤷ Free Forever Trial||PRODUCT NAME: A COMBINATION OF CEFTAZIDIME OR A SALT THEREOF, AND AVIBACTAM OR A SALT THEREOF; REGISTRATION NO/DATE: EU/1/16/1109/001 20160624|
|1480644||C20160041 00213||Estonia||⤷ Free Forever Trial||PRODUCT NAME: TSEFTASIDIIM/AVIBAKTAAM;REG NO/DATE: EU/1/16/1109 28.06.2016|
|>Patent Number||>Supplementary Protection Certificate||>SPC Country||>SPC Expiration||>SPC Description|
Make Better Decisions: Try a trial or see plans & pricing
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.